Renova Therapeutics Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $47.6M

  • Investors
  • 3

Renova Therapeutics General Information

Description

Operator of a bio-pharmaceutical research company designed to create a portfolio of definitive gene and peptide therapies. The company's bio-pharmacy is engaged in the research and development of gene and peptide therapies, single-dose gene therapies, and peptide infusion treatment, enabling medical professionals to treat congestive heart failure (CHF) and type 2 diabetes.

Contact Information

Website
www.renovatherapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 701 Palomar Airport Road
  • Suite 300
  • Carlsbad, CA 92011
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Vertical(s)
Life Sciences
Corporate Office
  • 701 Palomar Airport Road
  • Suite 300
  • Carlsbad, CA 92011
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Renova Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 02-Feb-2024 $47.6M Completed Clinical Trials - Phase 2
8. Grant 20-Sep-2019 Completed Clinical Trials - Phase 2
7. Later Stage VC (Series D1) 31-Jan-2017 Completed Product Development
6. Later Stage VC (Series D) 23-Feb-2016 Completed Product Development
5. Grant 01-Jan-2016 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series C) 30-Sep-2014 Completed Pre-Clinical Trials
3. Early Stage VC (Series B) 25-Feb-2012 Completed Product Development
2. Early Stage VC (Series A) 10-Aug-2009 $3.05M $3.05M Completed Startup
1. Grant 02-Sep-2011 $250K Completed Startup
To view Renova Therapeutics’s complete valuation and funding history, request access »

Renova Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series D
Series C
Series B 320,292 $0.001000 $1.23 $24.6 $24.6 1x $24.6 10.46%
Series A 305,000 $0.001000 $0.5 $10 $10 1x $10 9.96%
To view Renova Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Renova Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a bio-pharmaceutical research company designed to create a portfolio of definitive gene and peptide therapie
Biotechnology
Carlsbad, CA

Minneapolis, MN
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Renova Therapeutics Competitors (82)

One of Renova Therapeutics’s 82 competitors is DiaMedica Therapeutics, a Formerly VC-backed company based in Minneapolis, MN.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
DiaMedica Therapeutics Formerly VC-backed Minneapolis, MN
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
Korro Bio Formerly VC-backed Cambridge, MA
Taysha Gene Therapies Formerly VC-backed Dallas, TX
Cardurion Venture Capital-Backed Burlington, MA
You’re viewing 5 of 82 competitors. Get the full list »

Renova Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Heart, Lung, and Blood Institute Government
Biobrit Venture Capital Minority
National Institutes of Health Government
To view Renova Therapeutics’s complete investors history, request access »

Ready to get started?

Request a free trial

Renova Therapeutics FAQs

  • When was Renova Therapeutics founded?

    Renova Therapeutics was founded in 2009.

  • Where is Renova Therapeutics headquartered?

    Renova Therapeutics is headquartered in Carlsbad, CA.

  • What industry is Renova Therapeutics in?

    Renova Therapeutics’s primary industry is Biotechnology.

  • Is Renova Therapeutics a private or public company?

    Renova Therapeutics is a Private company.

  • What is Renova Therapeutics’s current revenue?

    The current revenue for Renova Therapeutics is .

  • How much funding has Renova Therapeutics raised over time?

    Renova Therapeutics has raised $78.1M.

  • Who are Renova Therapeutics’s investors?

    National Heart, Lung, and Blood Institute, Biobrit, and National Institutes of Health have invested in Renova Therapeutics.

  • Who are Renova Therapeutics’s competitors?

    DiaMedica Therapeutics, Alnylam Pharmaceuticals, Korro Bio, Taysha Gene Therapies, and Cardurion are some of the 82 competitors of Renova Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »